Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 107 (5) , 884-888
- https://doi.org/10.1016/s0161-6420(00)00077-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defectsNeurology, 1999
- Outer retinal dysfunction in patients treated with vigabatrinNeurology, 1999
- Vigabatrin-associated retinal cone system dysfunctionNeurology, 1998
- The influence of established and new antiepileptic drugs on visual perception: II. A controlled study in patients with epilepsy under long-term antiepileptic medicationEpilepsy Research, 1997
- The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteersEpilepsy Research, 1997
- Severe persistent visual field constriction associated with vigabatrinBMJ, 1997
- VigabatrinEpilepsia, 1995
- Afferent visual function after single dose application of -vinyl GABANeuro-Ophthalmology, 1995
- Distribution of GABA immunoreactivity in kainic acid-treated rabbit retinaExperimental Brain Research, 1994
- Place of Newer Antiepileptic Drugs in the Treatment of EpilepsyDrugs, 1993